Differential Neuroendocrine and Behavioral Responses to Cocaine in Lewis and Fischer Rats

Neuroendocrinology

Volumn 63, Issue 1, 1996, Pages 93-100

  Simar, Renée ^a   Saphier, David ^a,b   Goeders, Nick E ^a,b  

^a Departments of Pharmacology and Therapeutics   (United States)

^b LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

Adrenal steroids; Cocaine; Corticotropin; Corticotropin releasing hormone; Fischer rats; Lewis rats; Locomotor activity

Indexed keywords

COCAINE; CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; NORADRENALIN;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; HORMONE RESPONSE; HYPOPHYSIS ADRENAL SYSTEM; LOCOMOTION; MALE; NEUROENDOCRINE SYSTEM; NONHUMAN; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; RAT;

ADRENAL CORTEX; ADRENOCORTICOTROPIC HORMONE; ANIMALS; BEHAVIOR, ANIMAL; COCAINE; CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPOTHALAMUS; MALE; MOTOR ACTIVITY; PITUITARY GLAND; RATS; RATS, INBRED F344; RATS, INBRED LEW;

EID: 9044232152     PISSN: 00283835     EISSN: 14230194     Source Type: Journal    
DOI: 10.1159/000126940     Document Type: Article

References (44)

1. Siegel RK: Changing patterns of cocaine use: longitudinal observations, conscqucnccs and treatments; in Grabowski.1 (ed): Cocaine: Pharmacology, Effects, and Treatment of Abuse, Rockville, NIDA, 1984, pp 92-110.
2. Gawin FH, Klebcr HD: Abstinence symptomatology and psychiatric diagnosis in cocaine abusers, Arch Gen Psychiatry 1986:43:107-113.
3. Johanson C-E, Fischman M: The pharmacology of cocaine related to its abuse, Pharmacol Rev 1989;41:3-52.
4. Nestlcr EJ: Molecular mcchanisms of drug addiction, J Neurosci 1992;12:2439-2450.
5. Koob G: Drugs of abuse: Anatomy, pharmacology and function of reward pathways, Trends Pharmacol Sci 1992; 13:177-184.
6. Morse AC, Erwin VG, Jones BC: Strain and housing affect cocaine self-selection and open-field locomotor activity in mice, Pharmacol Biochem Behav 1993;45:905-912.
7. Weeks JR: Experimental morphine addiction: method forautomatic intravenous injections in unrestrained rats, Science 1962:138:143-144.
8. Spealman RD, Goldberg SR: Drug self-administration by laboratory animals: Control by schedules of reinforcement, Annu Rev Phar-macolToxicol 1978:18:313-339.
9. Stolcrman I: Drugs of abuse: Behavioural principles, methods and terms, Trends Pharmacol Sci 1992:13:170-176.
10. Ritz MC, George FR, DeFiebre CM, Meisch RA: Genetic differences in the establishment of ethanol as a reinforcer, Pharmacol Biochem Behav 1986:24:1089-1094.
11. George FR, Goldberg SR: Genetic approaches to the analysis of addiction processes, Trends Pharmacol Sci 1989;10:78-83.
12. Suzuki T, George FR, Meisch RA: Etonita/.ene delivered orally serves as a rcinforccr for Lewis but not Fischer 344 rats, Pharmacol Biochem Behav 1992:42:579-586.
13. Miscrendino MJD, Kosten TA, Guitart X, Chi S, Nestlcr EJ: Individual differences in vulnerability to drug-addiction: behavioral and biochemical correlates (abstract 450.12), 22nd Ann Meet Soc Neurosci, 1992, p 1078.
14. Piazza PV, Maccari S, Deminicre J-M, Le Moal M, Mormede P, Simon H: Corticosterone levels determine individual vulnerability to amphetamine self-administration, Proc Natl Acad Sci USA 1991:88:2088-2092.
15. Samyai Z, Biro E, Gardi J, Vccsemyes M, Julesz J, Telegdy G: Alterations of corticotro-pin-releasing factor-like immunoreactivity in different brain regions after acute cocaine administration in rats, Brain Res 1993;616:315-319.
16. Rivier C, Vale W: Cocaine stimulates adreno-corticotropin (AC I H) secretion through a cor-ticotropin-releasing factor (C'RF)-mcdiatcd mechanism, Brain Res 1987;422:403-406.
17. Moldow RL, Rischman AJ: Cocaine induced secretion of ACTH, beta-endorphin, and corticosterone, Peptides 1987:8:819-822.
18. Pilottc NS, Sharpe LG, Dax EM: Multiple, but not acute, infusions of cocaine alter the release of prolactin in male rats, Brain Res 1990:512: 197-112.
19. Saphicr D, Welch JE, Farrar GE, Goeders NE: Effects of intracerebroventricular and intrahy-pothalamic cocaine administration on adrenocortical secretion, Neuroendocrinologv 1993; 57:54-62.
20. Samyai Z, Biro E, Penke B, Telegdy G: The cocainc-induccd elevation of plasma corticosterone is mediated by endogenous corticotropin-releasing factor (CRF) in rats, Brain Res 1992;589:154-156.
21. Piazza P, Deminicre J, Maccari S, Molal M, Mormede P, Simon H: Individual vulnerability to drug self-administration: action of corticosterone on dopaminergic systems as a possible pathophysiological mechanism: in Willner P, Schcel-Kruger J (eds): The Mesolimbic Dopamine System: from Motivation to action, New York, Wiley, 1991, pp 474-495.
22. Sternberg EM, Glowa JR, Smith MA, Calogero AE, Listwak SJ, Aksentijevich S, Chrousos GP, Wilder R, Gold PW: Corticotropin-releasing hormone related behavioral and neuroendocrine responses to stress in Lewis and Fischer rats, Brain Res 1992:570:54-60.
23. Davis JK, Thorp RB, Maddox PA, Brown MB, Cassell GH: Murine respiratory mycoplasmosis in F344 and LEW rats: Evolution of lesions and lung lymphoid cell populations, Infect Im-mun 1982:36:720-729.
24. Sternberg EM, Hill JM, Chrousos GP, Kami-laris T, Listwak S, Gold PW, Wilder RL: Inflammatory mediator-induced hypothalamic-pituitary-adrcnal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats, Proc Natl Acad Sci USA 1989;86: 2374-2378.
25. Whitnall MH, Anderson KA, Lane CA, Mou-gey EH, Neta R, Perlstein RS: Decreased vasopressin content in parvocellular CRH neurosecretory system of Lewis rats, Neuroreport 1994;5:1635-1637.
26. Saphicr D, Welch JE: Central stimulation of adrenocortical secretion by 5-hydroxytrypta-mineiA agonists is mediated by sympathome-dullary activation, J Pharmacol Exp Ther 1994:270:905-917.
27. Piazza PV, Deminicre J-M, Le Moal M, Simon H: Factors that predict individual vulnerability to amphetamine self-administration, Science 1989,245:1511-1513.
28. George FR: Cocaine toxicity: Genetic evidence suggests different mechanisms of cocaine-induced seizures and lethality, Psychopharmacology 1991:104:307-311.
29. Schccl-KrUger J, Braestrup C, Nielson M, Go-lembiowska K, Mogilnicka E: Cocaine: Discussion on the role of dopamine in the biochemical mechanism of action: in Ellinwood EHJ, Kil-bcy MM (eds): Cocaine and Other Stimulants, New York, Plenum, 1977, pp 373-407.
30. Waynforth HB, Flecknell PA (eds): Experimental and Surgical Technique in the Rat, New York, Academic Press, 1992.
31. Vale W, Vaughan J, Yamamoto G, Bruhn T, Douglas C, Dalton D, Rivier C, Rivier J: Assay of corticotropin releasing factor: in Conn PM (ed): Methods in Enzymology, New York, Academic Press, 1983, pp 565-577.
32. Hcber D, Odell WD, Schcdewle H, Wolfsen AR: Improved iodination of peptides for radioimmunoassay and membrane radioreceptor assay, Clin Chem 1978;24:796-799.
33. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal Biochem 1976:72:248-254.
34. Glowa JR, Gcyer MA, Gold PW, Sternberg EM: Differential startle amplitude and corticosterone response in rats, Neuroendocrinology 1992;56:719-723.
35. Glowa JR, Sternberg EM, Gold PW: Differential behavioral response in LEW/N and F344/N rats: effects of corticotropin releasing hormone, Prog Neuropsychopharmacol Biol Psychiatry 1992;16:549-560.
36. Rivier C, Lee S: Stimulatory effect of cocaine on ACTH secretion: Role of the hypothalamus, Mol Cell Neurosci 1994:5:189-195.
37. Feldman S, Saphier D: Extrahypothalamic neural afTcrents and the role of ncurotransmit-tcrs in the regulation of adrenocortical secretion; in Rose FC (cd): The Control of the Hypo-thalamo-Pituitary-Adrenocortical Axis, Madison, International Universities Press, 1989, pp 297-316.
38. Beitner-Johnson D, Guitart X, Ncstler EJ: Dopaminergic brain reward regions of Lewis and Fischer rats display different levels of tyrosine hydroxylase and other morphine- and cocaine-regulated phosphoproteins, Brain Res 1991: 561:147-150.
39. Ortiz J, Nestler J: Fischer and Lewis rat strains differ in corticosterone regulation of tyrosine hydroxylase and other phosphoproteins in the ventral tegmental area (abstract 387.5), 23rd Ann Meet Soc Neurosci, 1993, p 942.
40. Chiueh CC, Kopin IJ: Centrally mediated release by cocaine of endogenous epinephrine and norepinephrine from the sympathoadrenal medullary system of unanesthesized rats, J Pharmacol ExpTher 1978;205:148-154.
41. George FR, Porrino LJ, Ritz MC, Goldberg SR: Inbred rat strain comparisons indicate different sites of action for cocaine and amphetamine locomotor stimulant effects, Psychopharmacology 1991:104:457-462.
42. Camp DM, Browman KE, Robinson TE: The effects of mcthamphctamine and cocaine on motor behavior and extracellular dopamine in the ventral striatum of Lewis versus Fischer 344 rats, Brain Res 1994;668:108-183.
43. Kostcn TA, Miserendion JD, Chi S, Nestler EJ: Fischer and Lewis rat strains show differential cocaine effects in conditioned place preference and behavioral sensitization but not in locomotor activity or conditioned taste aversion, J Pharmacol' Exp Ther 1994;269:137-144.
44. Guitart X, Beitner-Johnson D, Marby DW, Kostcn TA, Nestler EJ: Fischer and Lewis rat strains differ in basal levels of neurofilament proteins and their regulation by chronic morphine in the mcsolimbic dopamine system, Synapse 1992:12:242-253.